Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

HVO

Hvivo (HVO)

Hvivo Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:HVO
DateHeureSourceTitreSymboleSociété
14/12/202008h00UK RegulatoryOpen Orphan PLC MHRA approval for nasal COVID-19 vaccine trialLSE:HVOHvivo Plc
07/12/202008h00UK RegulatoryOpen Orphan PLC Venn Life Sciences contract winsLSE:HVOHvivo Plc
24/11/202017h27Alliance NewsAlliance NewsUK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head ExitsLSE:HVOHvivo Plc
24/11/202008h00UK RegulatoryOpen Orphan PLC Directors ChangeLSE:HVOHvivo Plc
19/11/202022h18Alliance NewsAlliance NewsIN BRIEF: Open Orphan To Lead Challenge Agent Development ConsortiumLSE:HVOHvivo Plc
19/11/202008h00RNS Non-RegulatoryOpen Orphan PLC Collaboration with HIC-VAC and Wellcome TrustLSE:HVOHvivo Plc
05/11/202017h32Alliance NewsAlliance NewsIN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza StudyLSE:HVOHvivo Plc
05/11/202008h00UK RegulatoryOpen Orphan PLC New GBP2.5m Influenza Challenge Study Contract WinLSE:HVOHvivo Plc
30/10/202012h07Alliance NewsAlliance NewsOpen Orphan Inks Two-Year Contract With Tier 1 German Pharma CompanyLSE:HVOHvivo Plc
30/10/202012h00UK RegulatoryOpen Orphan PLC Price Monitoring ExtensionLSE:HVOHvivo Plc
30/10/202008h51Alliance NewsAlliance News*Open Orphan Inks 2-Year Contract With Unnamed Tier 1 German Pharma CompanyLSE:HVOHvivo Plc
30/10/202008h10UK RegulatoryOpen Orphan PLC Exercise of Share OptionsLSE:HVOHvivo Plc
30/10/202008h00UK RegulatoryOpen Orphan PLC New 2-year contract with a tier 1 German companyLSE:HVOHvivo Plc
20/10/202016h59Alliance NewsAlliance NewsIN BRIEF: Open Orphan To Develop Covid Study Model For UK GovernmentLSE:HVOHvivo Plc
20/10/202008h00UK RegulatoryOpen Orphan PLC Contract Signed with UK GovernmentLSE:HVOHvivo Plc
16/10/202016h24Alliance NewsAlliance NewsIN BRIEF: Open Orphan In Talks With UK Government Over Corona StudyLSE:HVOHvivo Plc
16/10/202009h47UK RegulatoryOpen Orphan PLC Statement re further media commentLSE:HVOHvivo Plc
30/09/202019h37Alliance NewsAlliance NewsUK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue RiseLSE:HVOHvivo Plc
30/09/202008h00UK RegulatoryOpen Orphan PLC Interim Results for 6 months ended 30 June 2020LSE:HVOHvivo Plc
28/09/202020h34Alliance NewsAlliance NewsIN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study ContractLSE:HVOHvivo Plc
28/09/202008h00UK RegulatoryOpen Orphan PLC New GBP4.3m Challenge Study Contract WinLSE:HVOHvivo Plc
24/09/202018h35Alliance NewsAlliance NewsUK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail ContractLSE:HVOHvivo Plc
24/09/202008h00UK RegulatoryOpen Orphan PLC Statement re price movement and press speculationLSE:HVOHvivo Plc
23/09/202017h41UK RegulatoryOpen Orphan PLC Second Price Monitoring ExtnLSE:HVOHvivo Plc
22/09/202020h35Alliance NewsAlliance NewsIN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract WinLSE:HVOHvivo Plc
22/09/202008h30UK RegulatoryOpen Orphan PLC Exercise of Investor Warrants and Issue of SharesLSE:HVOHvivo Plc
22/09/202008h00UK RegulatoryOpen Orphan PLC New Contract WinLSE:HVOHvivo Plc
07/09/202008h00RNS Non-RegulatoryOpen Orphan PLC hVIVO present at 2020 ERS International CongressLSE:HVOHvivo Plc
10/08/202011h56Alliance NewsAlliance NewsIN BRIEF: Open Orphan Wins Contract With "Top 3" Pharma FirmLSE:HVOHvivo Plc
10/08/202008h00UK RegulatoryOpen Orphan PLC Major New Contract Win with Top 3 Pharma CompanyLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO

Dernières Valeurs Consultées